Cargando…

Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis

Epithelial ovarian cancer has become the most frequent cause of deaths among gynecologic malignancies. Our study elucidates the diagnostic performance of Risk of Ovarian Malignancy Algorithm (ROMA), Human epididymis secretory protein 4 (HE4) and cancer antigen (CA125). To compare the diagnostic accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suri, Arpita, Perumal, Vanamail, Ammalli, Prajwal, Suryan, Varsha, Bansal, Sanjiv Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397730/ https://www.ncbi.nlm.nih.gov/pubmed/34453074 http://dx.doi.org/10.1038/s41598-021-96552-9

Ejemplares similares

Association of inflammatory biomarker abnormalities with mortality in COVID-19: a meta-analysis
por: Suri, Arpita, et al.
Publicado: (2022)

A Study on the Serum γ-Glutamyltranspeptidase and Plasma Osteopontin in Alcoholic Liver Disease
por: Suri, Arpita, et al.
Publicado: (2021)

SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer
por: Perumal, Jayakumar, et al.
Publicado: (2019)

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis
por: Liu, Huiling, et al.
Publicado: (2023)

Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19
por: Khemka, Aakriti, et al.
Publicado: (2020)

CXCL12 expression by healthy and malignant ovarian epithelial cells
por: Machelon, Véronique, et al.
Publicado: (2011)

Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran
por: Farzaneh, Farah, et al.
Publicado: (2017)

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer
por: Wang, Huan, et al.
Publicado: (2016)

Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors
por: Zhang, Shuang, et al.
Publicado: (2019)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Leptomeningeal Carcinomatosis in Epithelial Ovarian Cancer: A Diagnostic Challenge
por: Tahir, Nayha, et al.
Publicado: (2021)

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
por: Li, Fake, et al.
Publicado: (2012)

Comparison of four malignancy risk indices in the detection of malignant ovarian masses
por: Aktürk, Erhan, et al.
Publicado: (2011)

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential
por: Warrenfeltz, Susanne, et al.
Publicado: (2004)

Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma
por: Roberts, Patrick, et al.
Publicado: (2012)

FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors
por: Kitade, Shoko, et al.
Publicado: (2016)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Meta-analysis of the diagnostic value of (18)F-FDG PET/CT in the recurrence of epithelial ovarian cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

HITAC for ovarian malignancy---Anesthesiologist’s challenge
por: Adhikari, Shreya Das, et al.
Publicado: (2022)

Diagnostic challenge for ovarian malignant melanoma in premenopausal women: Primary or metastatic?
por: Sbitti, Yassir, et al.
Publicado: (2011)

Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Diagnostic value of risk of malignancy index in the clinical evaluation of ovarian mass
por: Huwidi, Ali, et al.
Publicado: (2022)

Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours among patients in Lagos, Nigeria
por: Shittu, Khadijah Adebisi, et al.
Publicado: (2023)

p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
por: Cabral, Vinicius Duarte, et al.
Publicado: (2016)

Histomorphological Evaluation of Desmoplastic Tumor Stroma in Malignant Ovarian Surface Epithelial Tumors
por: Ahuja, Sana, et al.
Publicado: (2023)

Adiponectin to Leptin Ratio and its Association with Insulin Resistance in Women with Polycystic Ovarian Syndrome
por: Mishra, Pragya, et al.
Publicado: (2022)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors
por: Moon, Min Hoan, et al.
Publicado: (2023)

Epithelial Ovarian Carcinoma Types and the Coexistence of Ovarian Tumor Conditions
por: van Niekerk, Catharina. C., et al.
Publicado: (2011)

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Morphological parameters of ovarian masses and accuracy of the risk of malignancy index in diagnosing ovarian malignancy
por: Adilgereyeva, Akmaral S., et al.
Publicado: (2022)

A comparison of Doppler measures of ovarian blood flow between women with and without ovarian dysfunction and correlations of Doppler indices with ovarian dysfunction markers: a meta-analysis
por: Wang, Wei-Qiang, et al.
Publicado: (2023)

Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
por: Fujiwara, Hiroyuki, et al.
Publicado: (2014)

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
por: Cho, Hye Yon, et al.
Publicado: (2015)

The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy
por: Yamanaka, Shoichiro, et al.
Publicado: (2022)

Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel
por: Sehrawat, Urmila, et al.
Publicado: (2016)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Schwannoma mimicking ovarian malignancy
por: Conde Vasco, Inês, et al.
Publicado: (2022)

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
por: Anton, Cristina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p4b0roqsqngjdooqer99c95g1e